COMP <GO>
SWIM vs TMO // FREE CASH FLOW YIELD
Latham Group Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: SWIM 5
— TMO 7
▲ FREE CASH FLOW YIELD LEADER: SWIM
LAST: $7.26 (+2.98%) • MKT CAP: $854.1M
fcf-yield
4.45%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
fcf-yield
2.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SWIM VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SWIM | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 9.30% | -5.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.7x | 30.4x | -8.70 | SWIM | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.45% | 2.40% | +2.05 | SWIM | /fcf-yield <GO> |
| Operating Margin | 5.60% | 17.40% | -11.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.00% | 15.10% | -13.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 7.40% | 3.90% | +3.50 | SWIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.11 | 4.50 | -2.39 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | SWIM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.8 | 62.9 | +11.86 | SWIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 71.4x | 36.3x | +35.10 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $854.1M | $262.22B | -$261.36B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SWIM REV | TMO REV | SWIM GROSS % | TMO GROSS % | SWIM FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $545.9M | $44.56B | 33.4% | — | $38.0M | $6.29B |
| FY 2024 | $508.5M | $42.88B | 30.2% | — | $41.2M | $7.27B |
| FY 2023 | $566.5M | $42.86B | — | — | $116.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SWIM // BETA —
TMO // BETA 0.94